Teva Could Market Generic Lipitor by Month’s End, Calcalist Says

Teva Pharmaceutical Industries Ltd. could begin marketing a generic version of Lipitor by the end of the month through a partnership with India’s Ranbaxy Laboratories Ltd., Calcalist reported today, without saying how it obtained the information..

A message left on the answering machine of a Teva spokesman before office hours was not immediately answered.

Click here for web link

Before it's here, it's on the Bloomberg Terminal. LEARN MORE